Which assembler should i go for if i want to assemble genome of 1 -1.5 GB size. i have illumina paired end and mate pair reads of 101 bp length. how can i use mate paire reads for Scaffolding?
-
-
I'd try Allpaths-LG (http://www.broadinstitute.org/softwa...paths-lg/blog/) if your paired end reads mostly overlap (i.e. fragment size of ~180 bp). It will use your mate pairs for scaffolding. -
Thank you sarvidsson,
I have access to 96GB memory and 24 core machine. is it sufficiant to work with Allpaths-LG?Comment
-
96 GB can be a bit tight, 24 cores should be fine - I'd expect the assembly to run for up to 3 days. If you error correct and normalize the paired end reads prior to assembly (with e.g. BBNorm http://seqanswers.com/forums/showthread.php?t=49763) you typically reduce memory usage for the assembly.Comment
-
We have 100-200Mbp fungal assemblies that run out of memory (with AllPaths-LG) on 128GB nodes, but complete on 256GB nodes. I'm guessing memory may be a serious problem; you probably are going to need more.
Megahit is fast and seems to have a relatively low memory consumption, and Minia was designed for low memory consumption, so if AllPaths fails you might try those. Or, buy more memory, which will be essential if you plan to routinely assemble large genomes.Comment
-
With that amount of memory I'd recommend SGA...Minia is great too but there isn't a scaffolding option.Comment
-
Allpaths-LG is a good option if you have enough RAM and CPUs. Also I wonder whether one of your PE libraries are overlapping i.e. from Allpaths-LG doc "average separation size must be slightly less than twice the read size, such that the reads from a pair will likely overlap".Comment
-
Thank you all.
I think i have to go for SGA or minia due to lack of memory. is it a good option to use paired end reads for assembly and then go for scaffolding with mate pair data.?
which tool would be suitable for 101 bp mate pair data for scaffolding?Comment
-
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM
Comment